Skip to main content
. 2023 Jul 10;6(7):e2322505. doi: 10.1001/jamanetworkopen.2023.22505

Figure 1. Hyperpolypharmacy Program Tool.

Figure 1.

Tool uses the US Agency for Healthcare Research and Quality (AHRQ) SHARE (seek your patient’s participation; help your patient explore and compare treatment options; assess your patient’s values and preferences; reach a decision with your patient; and evaluate your patient’s decision) approach.23 Patients were able to decline or withdraw consent for participation at any point. CEASE indicates confirm, estimate, assess, sort, and eliminate.